Standout Papers
- The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements (2009)
- The schedule for the deficit syndrome: An instrument for research in schizophrenia (1989)
- The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2003 (2004)
- Negative symptoms of schizophrenia: new developments and unanswered research questions (2018)
- Deconstructing negative symptoms of schizophrenia: Avolition–apathy and diminished expression clusters predict clinical presentation and functional outcome (2013)
Immediate Impact
4 by Nobel laureates 25 from Science/Nature 115 standout
Citing Papers
Systematic literature review of schizophrenia clinical practice guidelines on acute and maintenance management with antipsychotics
2022 Standout
Oxytocin pathway gene networks in the human brain
2019 Standout
Works of Robert W. Buchanan being referenced
Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: Results from a randomized double blind placebo controlled pilot study
2013
Galantamine for the Treatment of Cognitive Impairments in People With Schizophrenia
2007
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Robert W. Buchanan | 10387 | 4207 | 2824 | 230 | 15.8k | |
| Alan Breier | 9156 | 3045 | 1888 | 275 | 15.9k | |
| Gary Remington | 11040 | 3003 | 2316 | 466 | 17.3k | |
| Donald Goff | 9247 | 5427 | 1328 | 284 | 19.6k | |
| Kristin S. Cadenhead | 7800 | 3677 | 2699 | 233 | 11.7k | |
| Henry A. Nasrallah | 8902 | 2529 | 1572 | 327 | 14.8k | |
| William T. Carpenter | 13773 | 3312 | 5625 | 248 | 19.0k | |
| Joachim Klosterkötter | 7769 | 3117 | 3521 | 281 | 12.7k | |
| Keith H. Nuechterlein | 12166 | 8359 | 3322 | 331 | 20.3k | |
| Joseph P. McEvoy | 15088 | 1601 | 3401 | 224 | 20.0k | |
| Barbara A. Cornblatt | 11206 | 4363 | 3608 | 279 | 15.0k |
All Works
Loading papers...